Evidence map›Paper›PMID 26438525›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Ptpn22 and Cd2 Variations Are Associated with Altered Protein Expression and Susceptibility to Type 1 Diabetes in Nonobese Diabetic Mice.

Heather I Fraser, Sarah Howlett, Jan Clark, Daniel B Rainbow, Stephanie M Stanford, Dennis J Wu, Yi-Wen Hsieh, Christian J Maine, Mikkel Christensen, Vijay Kuchroo and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Advancing Animal Models of Human Type 1 Diabetes.Cold Spring Harbor perspectives in medicine · 2024
    Review
  2. Deletion of Vβ3Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  3. Article
  4. Overexpression of theJournal of immunology (Baltimore, Md. : 1950) · 2021
    Article
  5. Influence ofFrontiers in immunology · 2021
    Review
  6. Article
  7. Article
  8. A NovelJournal of immunology (Baltimore, Md. : 1950) · 2018
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 3 countries.

Heather I FraserJuvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory, Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, United Kingdom;
Sarah HowlettJuvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory, Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, United Kingdom;
Jan ClarkJuvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory, Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, United Kingdom;
Daniel B RainbowJuvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory, Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, United Kingdom;
Stephanie M StanfordDivision of Cell Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037; La Jolla Institute for Allergy and Immunology, Type 1 Diabetes Research Center, La Jolla, CA 92037;
Dennis J WuDivision of Cell Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037; La Jolla Institute for Allergy and Immunology, Type 1 Diabetes Research Center, La Jolla, CA 92037;
Yi-Wen HsiehDivision of Cell Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037;
Christian J MaineDepartment of Immunology and Microbial Sciences, The Scripps Research Institute, La Jolla, CA 92037;
Mikkel ChristensenJuvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory, Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, United Kingdom;
Vijay KuchrooCenter for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115;
Linda A ShermanDepartment of Immunology and Microbial Sciences, The Scripps Research Institute, La Jolla, CA 92037;
Patricia L PodolinDepartment of Pharmacology, Merck Research Laboratories, Rahway, NJ 07065; and.
John A ToddJuvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory, Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, United Kingdom;
Charles A StewardThe Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1HH, United Kingdom.
Laurence B PetersonDepartment of Pharmacology, Merck Research Laboratories, Rahway, NJ 07065; and.
Nunzio BottiniDivision of Cell Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037; La Jolla Institute for Allergy and Immunology, Type 1 Diabetes Research Center, La Jolla, CA 92037;
Linda S WickerJuvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory, Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, United Kingdom; linda.wicker@cimr.cam.ac.uk.
La Jolla Institute for Immunology · USJuvenile Diabetes Research Foundation · GBJuvenile Diabetes Research Foundation · CAMerck & Co., Inc., Rahway, NJ, USA (United States) · USScripps Research Institute · USUniversity of Cambridge · GBHarvard University · USWellcome Sanger Institute · GB

Funding

Role of Negative Costimulation in Regulation of AutoimmunityP01AI039671 · NIAID · YALE UNIVERSITY · PI David A. Hafler · 1996 to 2026
$51.7M
Effects of insulin-dependent diabetes resistance alleles on CD8 tolerance in NODU01AI070351 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI SHERMAN, LINDA A · 2006 to 2011
$5.4M
PTPN22 AND AUTOIMMUNITYR01AI070544 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BOTTINI, NUNZIO · 2008 to 2019
$4.0M
IMMUNE TOLERANCE NETWORK-266015416-266015416N01AI015416 · NIAID · REGENTS OF THE UNIVERSITY OF C · PI BLUESTONE, JEFFREY A · 2002 to 2006
–
NIAID NIH HHS AI15416NIAID NIH HHS N01 AI015416NIAID NIH HHS P01 AI039671NIAID NIH HHS P01AI039671NIAID NIH HHS R01 AI070544NIAID NIH HHS R01AI070544NIAID NIH HHS U01 AI070351NIAID NIH HHS U01AI070351Wellcome Trust 091157Wellcome Trust 100140
6 · The paper itself

Abstract

By congenic strain mapping using autoimmune NOD.C57BL/6J congenic mice, we demonstrated previously that the type 1 diabetes (T1D) protection associated with the insulin-dependent diabetes (Idd)10 locus on chromosome 3, originally identified by linkage analysis, was in fact due to three closely linked Idd loci: Idd10, Idd18.1, and Idd18.3. In this study, we define two additional Idd loci--Idd18.2 and Idd18.4--within the boundaries of this cluster of disease-associated genes. Idd18.2 is 1.31 Mb and contains 18 genes, including Ptpn22, which encodes a phosphatase that negatively regulates T and B cell signaling. The human ortholog of Ptpn22, PTPN22, is associated with numerous autoimmune diseases, including T1D. We, therefore, assessed Ptpn22 as a candidate for Idd18.2; resequencing of the NOD Ptpn22 allele revealed 183 single nucleotide polymorphisms with the C57BL/6J (B6) allele--6 exonic and 177 intronic. Functional studies showed higher expression of full-length Ptpn22 RNA and protein, and decreased TCR signaling in congenic strains with B6-derived Idd18.2 susceptibility alleles. The 953-kb Idd18.4 locus contains eight genes, including the candidate Cd2. The CD2 pathway is associated with the human autoimmune disease, multiple sclerosis, and mice with NOD-derived susceptibility alleles at Idd18.4 have lower CD2 expression on B cells. Furthermore, we observed that susceptibility alleles at Idd18.2 can mask the protection provided by Idd10/Cd101 or Idd18.1/Vav3 and Idd18.3. In summary, we describe two new T1D loci, Idd18.2 and Idd18.4, candidate genes within each region, and demonstrate the complex nature of genetic interactions underlying the development of T1D in the NOD mouse model.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideAllelesAnimalsB-LymphocytesCD2 AntigensChromosomes, MammalianDiabetes Mellitus, Type 1Gene Expression RegulationGenetic LociHumansMiceMice, Inbred NODMice, TransgenicMolecular Sequence DataProtein Tyrosine Phosphatase, Non-Receptor Type 22CD2 AntigensProtein Tyrosine Phosphatase, Non-Receptor Type 22Ptpn22 protein, mouse

Identifiers

PMID26438525
PMCPMC4635565
OpenAlexW2235875870

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.